Related Experiment Video
Updated: May 10, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Osteosarcoma: evolution of treatment paradigms.
Norman Jaffe1, Ajay Puri, Hans Gelderblom
1Children's Cancer Hospital, University of Texas M.D Anderson Cancer Center, Houston, TX 77030, USA.
Sarcoma
|June 20, 2013
Summary
Chemotherapy has significantly improved osteosarcoma survival rates over five decades, but progress has stalled in the last 30 years. New agents and a multidisciplinary approach are crucial for future advancements in osteosarcoma treatment.
Area of Science:
- Oncology
- Medical History
Background:
- Osteosarcoma treatment has seen significant advancements.
- Chemotherapy has played a pivotal role in improving patient survival.
Purpose of the Study:
- To review the historical contribution of chemotherapy to osteosarcoma treatment.
- To analyze the evolution of osteosarcoma survival rates over the past 50 years.
- To identify future directions for osteosarcoma therapy.
Main Methods:
- Literature review of chemotherapy's impact on osteosarcoma.
- Analysis of survival data over five decades.
- Discussion of current treatment strategies and future needs.
Main Results:
- Chemotherapy led to a fivefold increase in osteosarcoma survival initially.
- Survival rates have plateaued over the last 30 years despite initial gains.
- A multidisciplinary approach is essential for combating osteosarcoma.
Conclusions:
- While chemotherapy revolutionized osteosarcoma treatment, further innovation is required.
- Exploring novel therapeutic agents is critical for improving patient outcomes.
- Continued research and a combined treatment strategy are necessary for overcoming osteosarcoma.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...